Assignee
KINDEX PHARMACEUTICALS INC
US·4 granted patents·1 pending application·0 citations·filing 2013–2018
Top patents by PatentIndex Score
5 records- 0156US8829056B2Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methodsKINDEX PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·0 cites·7 claims
- 0246US10343977B2Tetrahydro-isohumulone derivatives, methods of making and usingKINDEX PHARMACEUTICALS INC·Filed 2017·Granted Jul 9, 2019·0 cites·1 claims
- 0342US2020179308A1Use of isohumulones and derivatives thereof to treat polycystic ovary syndromeKINDEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0437US9828331B2Tetrahydro-isohumulone derivatives, methods of making and usingKINDEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·0 cites·1 claims
- 0533US9340479B2Methods of synthesizing alpha acids and substantially enantiomerically pure compositions thereofKINDEX PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·0 cites·27 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →